PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization
Abstract
While acute promyelocytic leukemia (APL) is always driven by fusions involving one of the three retinoic acid receptors, why PML and RARA are the preferred fusion partners has remained largely unsettled. Here, we demonstrate that corepressor (NCoR) binding onto the RARA moiety of PML::RARA is required for hematopoietic progenitor immortalization. We establish that PML-mediated tethering of the UBC9 SUMO-conjugating enzyme onto PML::RARA enforces SUMO2 conjugation of multiple RARA partner proteins, notably the NCoR complex, boosting its repressive power. PML mutants that fail to recruit UBC9 yield PML::RARA fusions that promote neither NCoR sumoylation nor transformation. Conversely, direct UBC9/RARA fusion drives both efficient corepressor complex sumoylation and immortalization. Sumoylation inhibitors reactivate retinoic acid target genes in PML::RARA-expressing, but not in RARA-expressing, progenitors and trigger APL differentiation. Thus, fusion of PML to RARA entails an unexpected gain of function that boosts RARA-mediated transcriptional repression through sumoylation of PML::RARA-bound proteins, explaining the recurrent implication of PML and RARA in APL pathogenesis.
....
Related
- Genome-wide structural variant landscape following HDR-enhanced CRISPR editing in human hematopoietic stem and progenitor cells
- Stathmin 1 regulates mitophagy and non-proliferative cellular function in hematopoietic stem and progenitor cells
- Equine (Equus caballus) primary post-natal brain-derived cells: immortalization and preliminary reprogramming attempts to induced pluripotent stem cells.
- Enhancer Tuning by Sequence-Specific Repressors
- Multiplexed CRISPRi reveals a transcriptional switch between KLF activators and repressors in the maturing neocortex.
BibTeX
@article{wu2026pmldriven,
title = {{PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization}},
author = {Hsin Chieh Wu and Emmanuel Laplantine and Cécile Esnault and Michiko Niwa-Kawakita and Yi Zhang and Viviane de Almeida Bastos and Marie-Claude Geoffroy and Hugues de Thé},
journal = {Journal of Experimental Medicine},
year = {2026},
month = aug,
doi = {10.1084/jem.20252333},
url = {https://hal.science/hal-05775544v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization
AU - Hsin Chieh Wu
AU - Emmanuel Laplantine
AU - Cécile Esnault
AU - Michiko Niwa-Kawakita
AU - Yi Zhang
AU - Viviane de Almeida Bastos
AU - Marie-Claude Geoffroy
AU - Hugues de Thé
PY - 2026
DA - 2026/08/28
JO - Journal of Experimental Medicine
DO - 10.1084/jem.20252333
UR - https://hal.science/hal-05775544v1
AB - While acute promyelocytic leukemia (APL) is always driven by fusions involving one of the three retinoic acid receptors, why PML and RARA are the preferred fusion partners has remained largely unsettled. Here, we demonstrate that corepressor (NCoR) binding onto the RARA moiety of PML::RARA is required for hematopoietic progenitor immortalization. We establish that PML-mediated tethering of the UBC9 SUMO-conjugating enzyme onto PML::RARA enforces SUMO2 conjugation of multiple RARA partner proteins, notably the NCoR complex, boosting its repressive power. PML mutants that fail to recruit UBC9 yield PML::RARA fusions that promote neither NCoR sumoylation nor transformation. Conversely, direct UBC9/RARA fusion drives both efficient corepressor complex sumoylation and immortalization. Sumoylation inhibitors reactivate retinoic acid target genes in PML::RARA-expressing, but not in RARA-expressing, progenitors and trigger APL differentiation. Thus, fusion of PML to RARA entails an unexpected gain of function that boosts RARA-mediated transcriptional repression through sumoylation of PML::RARA-bound proteins, explaining the recurrent implication of PML and RARA in APL pathogenesis. ....
SN - 0022-1007
SN - 1540-9538
ER -